GlassScriptPhysician profile
Dylan J Kuon
NPI 1851856389
$3,187.82
in general payments reported to CMS, 2019-2025
30 companies · $590 in 2025
The $590 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.34 · 2022: $569 · 2023: $1,312 · 2024: $671 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,572.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $529.83 | 2023-2025 | Gemtesa |
| Abbvie INC. | $456.71 | 2023-2025 | |
| Teleflex LLC | $296.02 | 2023-2024 | Urolift |
| Astellas Pharma US INC | $238.87 | 2022-2024 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $183.23 | 2022-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $149.47 | 2022-2024 | |
| Urogen Pharma, INC. | $128.67 | 2023-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $102.95 | 2022-2024 | Xiaflex |
| Hollister Incorporated | $92.72 | 2021-2024 | Infyna Chic |
| Procept Biorobotics Corporation | $90.84 | 2023 | Aquabeam Robotic System |
| Accord Healthcare, INC. | $90.71 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $86.22 | 2023-2024 | Keytruda, Lynparza |
| Boston Scientific Corporation | $85.64 | 2022-2023 | Ams 800 Artificial Urinary Sphincter |
| Olympus America INC. | $85.43 | 2025 | Itind System |
| Coloplast Corp | $70.33 | 2022-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $68.65 | 2023-2024 | |
| Laborie Medical Technologies Corp. | $53.00 | 2025 | |
| Urovant Sciences INC | $48.98 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $47.13 | 2022-2024 | |
| Janssen Biotech, INC. | $42.44 | 2023-2025 | Erleada |
| Endo USA, INC. | $36.46 | 2024-2025 | Xiaflex |
| Tolmar Pharmaceuticals, INC. | $33.26 | 2022 | |
| Myovant Sciences INC. | $32.23 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $29.09 | 2022 | |
| Antares Pharma, INC. | $21.30 | 2023 | Nocdurna, Tlando, Xyosted |
| Blue Earth Diagnostics | $20.92 | 2022 | |
| 180 Medical, INC. | $20.47 | 2023 | Cure Ultra Catheter |
| Abc Home Medical Supply, INC. | $18.48 | 2024 | |
| Sun Pharmaceutical Industries INC. | $14.10 | 2024 | |
| Telix Pharmaceuticals | $13.67 | 2023 | Illuccix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Kuon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.